Abbott J Haxby, Robertson M Clare, McKenzie Joanne E, Baxter G David, Theis Jean-Claude, Campbell A John
Centre for Physiotherapy Research, School of Physiotherapy, University of Otago, Dunedin, New Zealand.
Trials. 2009 Feb 8;10:11. doi: 10.1186/1745-6215-10-11.
Non-pharmacological, non-surgical interventions are recommended as the first line of treatment for osteoarthritis (OA) of the hip and knee. There is evidence that exercise therapy is effective for reducing pain and improving function in patients with knee OA, some evidence that exercise therapy is effective for hip OA, and early indications that manual therapy may be efficacious for hip and knee OA. There is little evidence as to which approach is more effective, if benefits endure, or if providing these therapies is cost-effective for the management of this disorder. The MOA Trial (Management of OsteoArthritis) aims to test the effectiveness of two physiotherapy interventions for improving disability and pain in adults with hip or knee OA in New Zealand. Specifically, our primary objectives are to investigate whether:1. Exercise therapy versus no exercise therapy improves disability at 12 months;2. Manual physiotherapy versus no manual therapy improves disability at 12 months;3. Providing physiotherapy programmes in addition to usual care is more cost-effective than usual care alone in the management of osteoarthritis at 24 months.
This is a 2 x 2 factorial randomised controlled trial. We plan to recruit 224 participants with hip or knee OA. Eligible participants will be randomly allocated to receive either: (a) a supervised multi-modal exercise therapy programme; (b) an individualised manual therapy programme; (c) both exercise therapy and manual therapy; or, (d) no trial physiotherapy. All participants will continue to receive usual medical care. The outcome assessors, orthopaedic surgeons, general medical practitioners, and statistician will be blind to group allocation until the statistical analysis is completed. The trial is funded by Health Research Council of New Zealand Project Grants (Project numbers 07/199, 07/200).
The MOA Trial will be the first to investigate the effectiveness and cost-effectiveness of providing physiotherapy programmes of this kind, for the management of pain and disability in adults with hip or knee OA.
Australian New Zealand Clinical Trials Registry ref: ACTRN12608000130369.
非药物、非手术干预措施被推荐作为髋膝关节骨关节炎(OA)的一线治疗方法。有证据表明运动疗法对减轻膝关节OA患者的疼痛和改善功能有效,有一些证据表明运动疗法对髋关节OA有效,还有早期迹象表明手法治疗可能对髋膝关节OA有效。关于哪种方法更有效、益处是否持久,或者提供这些疗法对该疾病的管理是否具有成本效益,几乎没有证据。骨关节炎管理(MOA)试验旨在测试两种物理治疗干预措施对改善新西兰髋或膝关节OA成人的残疾和疼痛的有效性。具体而言,我们的主要目标是调查:1. 运动疗法与不进行运动疗法相比,在12个月时是否能改善残疾状况;2. 手法物理治疗与不进行手法治疗相比,在12个月时是否能改善残疾状况;3. 在24个月时,除常规护理外提供物理治疗方案在骨关节炎管理中是否比单独的常规护理更具成本效益。
这是一项2×2析因随机对照试验。我们计划招募224名髋或膝关节OA患者。符合条件的参与者将被随机分配接受以下治疗:(a)一项有监督的多模式运动疗法方案;(b)一项个体化手法治疗方案;(c)运动疗法和手法治疗两者;或者,(d)不接受试验性物理治疗。所有参与者将继续接受常规医疗护理。结果评估者、骨科医生、全科医生和统计学家在统计分析完成之前将对分组情况不知情。该试验由新西兰健康研究委员会项目资助(项目编号07/199、07/200)。
MOA试验将是首个调查此类物理治疗方案对髋或膝关节OA成人疼痛和残疾管理的有效性及成本效益的试验。
澳大利亚新西兰临床试验注册库编号:ACTRN12608000130369。